<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="LuYichen(617) 432-4182(617) 432-8348yichenlu@hsph.harvard.edu1EssexMax(617) 432-2334(617) 739-8348messex@hsph.harvard.edu2ChanyasulkitChriscchanyas@hsph.harvard.edu3[ID1], grid.38142.3c000000041936754XDept. Immunology &amp;amp; Infectious, Diseases," exact="Harvard School of Public Health," post="[ID2], grid.38142.3c000000041936754XDept. Immunology &amp;amp; Infectious, Diseases, Harvard School of"/>
 <result pre="School of Public Health, [ID2], grid.38142.3c000000041936754XDept. Immunology &amp;amp; Infectious, Diseases," exact="Harvard School of Public Health," post="[ID3], grid.38142.3c000000041936754X, Dept of Immunology &amp;amp; Infectious Diseases, Harvard"/>
 <result pre="Public Health, [ID3], grid.38142.3c000000041936754X, Dept of Immunology &amp;amp; Infectious Diseases," exact="Harvard School of Public Health," post="ShaoYimingyshao08@gmail.com[], grid.198530.60000000088032373State Key Laboratory for Infectious Disease Prevention and"/>
 <result pre="Prevention and Control, National Center for AIDS/STD Control and Prevention," exact="Chinese Center for Disease Control and Prevention," post="epub: 2012-9-95773(C) , This article is made available via"/>
 <result pre="source. These permissions are granted for the duration of the" exact="World Health Organization" post="(WHO) declaration of COVID-19 as a global pandemic. Abstract"/>
 <result pre="The Brazilian government attempted negotiations for a lower price with" exact="Merck" post="beginning in November 2006. They threatened Merck with a"/>
 <result pre="lower price with Merck beginning in November 2006. They threatened" exact="Merck" post="with a compulsory license unless Brazil could sell efavirenz"/>
 <result pre="Campaign and South Africa’s Competition Commission filed a lawsuit against" exact="GlaxoSmithKline" post="and Boehringer Ingelheim. These two companies were accused of"/>
 <result pre="South Africa’s Competition Commission filed a lawsuit against GlaxoSmithKline and" exact="Boehringer Ingelheim." post="These two companies were accused of charging exorbitant prices"/>
 <result pre="accused of charging exorbitant prices for ritonavir, lamivudine, and nevirapine." exact="GlaxoSmithKline" post="and Boehringer Ingelheim were also found guilty of violating"/>
 <result pre="charging exorbitant prices for ritonavir, lamivudine, and nevirapine. GlaxoSmithKline and" exact="Boehringer Ingelheim" post="were also found guilty of violating the Competition Act"/>
 <result pre="granted to femara, tarceva, and taxotere. Glivec was exempt because" exact="Novartis" post="had promised to provide glivec free of charge to"/>
 <result pre="on the Thai government. Efavirenz, which is recommended by the" exact="World Health Organization" post="(WHO) for HIV/AIDS treatment, has been named one of"/>
 <result pre="components for first and second line therapy. The price from" exact="Merck" post="was $468 per patient per year, which was more"/>
 <result pre="price of Indian generics. With Merck’s original price, the Thai" exact="Ministry of Health" post="(MOH) was only able to cover two-thirds of the"/>
 <result pre="two-thirds of the population in need. After failed negotiations with" exact="Merck" post="[18, 19], the Thai government issued a compulsory license"/>
 <result pre="To prevent the infection disease outbreaks To save lives Thai" exact="Ministry of Health" post="committee also successfully used a compulsory license as an"/>
 <result pre="government used the threat of a compulsory license to force" exact="Bayer" post="to significantly lower its price and thus saved $276"/>
 <result pre="holder before issuing the compulsory license. After failed negotiation with" exact="GlaxoSmithKline" post="and Boehringer Ingelheim, for a voluntary license and with"/>
 <result pre="issuing the compulsory license. After failed negotiation with GlaxoSmithKline and" exact="Boehringer Ingelheim," post="for a voluntary license and with petition from Rwanda"/>
 <result pre="for infectious diseases as soon as possible. According to Joint" exact="United Nations" post="Programme on HIV/AIDS [15] Global AIDS Report, there were"/>
 <result pre="drug combination pill. Due to the patent issues, China’s State" exact="Food and Drug Administration" post="(SFDA) does not accept generic drug applications for these"/>
 <result pre="1992 and 1993. By 2005, 56 products passed the US" exact="Food and Drug Administration" post="(FDA) certification with a sales revenue reaching US$175 million."/>
 <result pre="and that the successful operation of the UN Children’s Fund," exact="Médecins Sans Frontières," post="and other aid efforts rely on the low cost"/>
 <result pre="Developed Countries It is reported in the Journal of the" exact="American Medical Association" post="that the U.S. President’s Emergency Plan for AIDS Relief"/>
 <result pre="in the Journal of the American Medical Association that the" exact="U.S. President’s Emergency Plan for AIDS Relief" post="(PEPFAR) saved an estimated $323,343,256 from 2005 to 2008"/>
 <result pre="the crisis. A good example is the US government forcing" exact="Bayer" post="to reduce the price of Cipro using the compulsory"/>
 <result pre="Health (2011) Introduction of the national TB epidemic status by" exact="Ministry of Health." post="http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohjbyfkzj/s3590/201103/51027.htm 30.UN News Center (2008) Drug-resistant tuberculosis on the"/>
</results>
